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Heparan sulfate (HS) glycosaminoglycans are essen-
tial modulators of fibroblast growth factor (FGF) activ-
ity and appear to act by coupling particular forms of
FGF to appropriate FGF receptors. During neural devel-
opment, one particular HS proteoglycan is able to rap-
idly switch its potentiating activity from FGF-2, as neu-
ral precursor cell proliferation occurs, to FGF-1, as
neuronal differentiation occurs. Using various analyti-
cal techniques, including chemical and enzymatic cleav-
age, low pressure chromatography, and strong anion-
exchange high performance liquid chromatography, we
have analyzed the different HSs expressed during these
crucial developmental stages. There are distinct alter-
ations in patterns of 6-O-sulfation, total chain length,
and the number of sulfated domains of the HS from the
more mature embryonic brain. These changes correlate
with a switch in the ability of the HS to potentiate the
actions of FGF-1 in triggering cell differentiation. It
thus appears that each HS pool is designed to function
in the modulation of an intricate interaction with a spe-
cific growth factor and its cognate receptor, and sug-
gests tightly regulated expression of specific, bioactive
disaccharide sequences. The data can be used to con-
struct a simple model of controlled variations in HS
chain structure which have functional consequences at
a crucial stage of neuronal maturation.
Heparin-binding fibroblast growth factors (FGFs)1 are essen-
tial regulators of mitogenesis and differentiation for the pre-
cursor cells of the mammalian central nervous system (1). As in
many tissues, the bioactivity of the FGFs is partially regulated
by the glycosaminoglycan heparan sulfate (HS). These carbo-
hydrate chains are normally found attached to core proteins
and cells lacking these heparan sulfate proteoglycans (HSPGs)
are unable to transduce an FGF signal (2, 3). One current
hypothesis is that HSs serve to couple FGFs to specific HS-
binding regions on competent FGF receptors (FGFRs) to form
activating ternary complexes (4, 5). We have previously puri-
fied two different species of HSPG from embryonic murine
neuroepithelia: from embryonic day 10 (E10) cells, when an
HSPG with an affinity for FGF-2 was found and whose sugar
chains are herein designated as HS2, and from E12 neuroepi-
thelial cells, when an HSPG with an affinity for FGF-1 is
expressed, and whose sugar chains are called HS1 (6, 7). This
switch in HSPG activating activity was coincident with a sim-
ilar switch in FGF expression. As the HSPG core protein car-
rying the two HS species appeared to be the same (6) then
presumably differences in HS structure between E10 and E12
must account for the change in FGF specificity.
As specific HS species are essential to FGF activation,
knowledge of the structures is clearly crucial to understanding
their potentiating functions. Variation in HS species arises
from the synthesis of non-random, highly sulfated sequences of
sugar residues which are separated by unsulfated regions of
disaccharides containing N-acetylated glucosamine. The initial
conversion of N-acetylglucosamine to N-sulfoglucosamine cre-
ates a focus for other modifications, including epimerization of
glucuronic acid to iduronic acid and a complex pattern of O-
sulfations on glucosamine or iduronic acids (8, 9). In addition,
within the non-modified, low sulfated, N-acetylated sequences,
the hexuronate residues remain as glucuronate, whereas in the
highly sulfated N-sulfated regions, the C-5 epimer iduronate
predominates (10–12). This limits the number of potential
disaccharide variants possible in any given chain but not the
abundance of each. Most modifications occur in the N-sulfated
domains, or directly adjacent to them, so that in the mature
chain there are regions of high sulfation separated by domains
of low sulfation (12–15). This pattern distinguishes HS from
heparin, which is essentially highly sulfated along its entire
length. Some of these modifications have been shown to be
essential in creating unique binding sites for molecules such as
antithrombin III, FGF-2, hepatocyte growth factor, and inter-
feron-g (16–21). The possibility therefore exists that such mod-
ifications may create specific binding sites for different mem-
bers of the FGF family and many other extracellular matrix
molecules.
This study presents a detailed structural comparison of two
HS preparations: HS1 from E12 primary murine neuroepithe-
lia and HS2 from E10 primary murine neuroepithelia. (22). It
has now been well established that cells are capable of chang-
ing both the glycosaminoglycan moiety attached to a specific
core protein, and the sulfation patterns of HSs in culture (23–
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27), just as they do over the course of development, injury, and
disease (23, 28, 29). The main aim of this study was to elucidate
the structures of the two HS species which mediate either
mitogenesis or differentiation in vivo, and to determine the
structural properties that may account for the selectivity for
the two FGFs. Although direct sequencing of whole HS chains
is not yet feasible, methods for identifying specific structural
elements within a pool of similar chains are available. The
conjoint use of heparin lyases and nitrous acid digestion, low
pressure chromatography, HPLC, and a unique tetrasaccha-
ride analysis have allowed us to elucidate subtle structural and
compositional differences between mixtures. The results of the
structural analysis have led to the construction of a model for
the changing HS pools.
EXPERIMENTAL PROCEDURES
Materials—Trypsin was supplied by Calbiochem and DNase from
Boehringer Mannheim. D-[6-3H]Glucosamine (specific activity 21 Ci/
mmol) was obtained from Amersham Life Science. Heparitinases I (EC
4.2.2.8), II (no EC number assigned), and III (EC 4.2.2.7) and chon-
droitin ABC lyase (EC 4.2.2.4) were obtained from Seikagaku Kogyo
Co., Tokyo, Japan. Heparitinase IV was from Sigma (Sydney, Austra-
lia). Cell culture media was supplied by Life Technologies, Inc. Bio-Gel
P-2 and P-10 were from Bio-Rad Laboratories. CL-6B gel, DEAE-Sepha-
cel, columns, peristaltic pumps, fraction collectors, and tubing were
from Pharmacia Biotech Inc. (Sydney, Australia). ProPac PA1 analyti-
cal columns for the HPLC were from Dionex (Surrey, United Kingdom).
Centriflo CF25 Membrane Cones were supplied by Amicon (Sydney,
Australia). Scintillant (Ultima Gold) was from Packard (Melbourne,
Australia) as were the scintillation vials. All chromatographic proce-
dures were carried out a minimum of 3 times, and the standard errors
on all peaks reported in this study were never more than 8%.
Cell Culture and Labeling—Primary neuroepithelial cells were
grown in 10% FCS/Dulbecco’s modified Eagle’s medium and 2 ng/ml
FGF-2 in 24-well tissue culture plates at a density of 100,000 cells/well
for E10, and 200,000 cells/well for E12. Post-plating (30–60 min), 20
mCi/ml [3H]glucosamine was added. Cultures were further incubated
for 3–4 days, with the E12 cells being at confluence. HS from these
preparations was designated HS2 and HS1 for E10- and E12-derived
HS, respectively. The conditioned medium was removed and centri-
fuged (1000 rpm for 5 min) to remove any cell debris and stored at
220 °C until required.
Preparation of Intact Heparan Sulfate Chains—The conditioned me-
dia was subjected to ion-exchange chromatography on a DEAE-Sepha-
cel column (3 ml) equilibrated in 150 mM NaCl with phosphate-buffered
saline, pH 7.2. The media was manually loaded onto the column and
eluted under gravity. The column was washed with 10 column volumes
of 250 mM NaCl in 50 mM phosphate-buffered saline, pH 7.2. The bound
material was eluted with 1 M NaCl in 50 mM phosphate-buffered saline
and 2-ml fractions collected. Fractions containing the [3H]glucosamine-
labeled glycosaminoglycans were pooled, concentrated, and desalted on
Centriflo Cones (as per manufacturer’s instructions), freeze dried, and
resuspended in a minimal volume (100–500 ml) of neuraminidase buffer
(25 mM sodium acetate, pH 5.0). Samples were treated with neuramin-
idase (0.25 unit/sample) for 4 h. Five volumes of 100 mM Tris acetate,
pH 8.0, were then added to the sample which was then digested with
chondroitin ABC lyase (0.25 unit/sample) for 4 h at 37 °C and further
digested overnight with an equal amount of fresh enzyme. Finally, the
core protein and the lyases were digested away with Pronase (1/5 total
volume of 10 mg/ml Pronase in 500 mM Tris acetate, 50 mM calcium
acetate, pH 8.0) at 37 °C for 24 h. The entire mixture was then diluted
1:10 with deionized water, passed through a 2-ml DEAE-Sephacel col-
umn, eluted as described previously, and 1-ml fractions collected. The
sample was finally desalted on a 1 3 35-cm Bio-Gel P-2 column, the Vo
fraction collected and freeze dried.
Heparan Sulfate Characterization—To remove HS chains from trace
amounts of core protein, samples were incubated in 500 mM NaOH, 1 M
NaBH4 for 16 h at 4 °C and neutralized to pH 7 with glacial acetic acid.
Concentrated ammonium bicarbonate was added and after the bubbling
stopped, samples were run on a CL-6B column (1 3 120 cm) for sizing
of the released HS chains (30). Binding experiments were performed on
these HS preparations as described under “Results.”
Nitrous Acid Treatment of HS Chains—HS was chemically depo-
lymerized by low pH HNO2 (pH ,1.5) as described by Shively and
Conrad (31) and modified by Bienkowski and Conrad (32). Linkages
susceptible to low pH HNO2 are those containing N-sulfates of the type
GlcNSO3(66S)a1–4UA(62S) (11), whereas the resistant linkages are
UA a1–4 (GlcNAc(66S)a1–4GlcA)n-GlcNSO3. A small portion of the
mixture was run on a Bio-Gel P-10 column (1 3 200 cm) to obtain a
profile of the fragments released by this treatment and the rest of the
mixture was separated on a Bio-Gel P-2 column (1 3 120 cm) to isolate
disaccharides and tetrasaccharides for strong anion exchange-high
pressure liquid chromatography (SAX-HPLC).
Lyase Depolymerization of HSPGs—Heparitinase (heparitinase I),
heparitinase II, and heparitinase IV were used at a concentration of 25
milliunits/ml in 100 mM sodium acetate, 0.2 mM calcium acetate, pH 7.0.
Heparinase was used at a concentration of 50 milliunits/ml in the same
buffer. Heparitinase I (also known as heparinase III) cleaves mainly at
GlcNR(66S)a1–4 GlcA linkages (R 5 N-acetyl or N-sulfate moiety) (11,
33) creating resistant products with the structural motif GlcA a1–
4(GlcNSO3(66S)a1–4IdoA(12S))n a1–4 GlcNR. Heparitinase II (also
known as heparinase II) has a wide spectrum of activity cleaving
linkages of the type GlcNSO3(66S)a1–4IdoA/Glc leading primarily to
the generation of disaccharides from HS (33). Heparinase (also known
as heparitinase III) cleaves at linkages of the type GlcNSO3(66)a1–
4IdoA(2S) (11, 33) creating resistant sequences of structure
IdoA(2S)a1–4(GlcNR(66S)a1–4UA)b1–4GlcNSO3(66S) (R 5 N-acetyl
or N-sulfate moiety) (11, 33). Samples were digested in the presence of
100 mg of non-labeled carrier HS. For single enzyme digests, samples
were separately incubated at 37 °C for 16 h and then a second aliquot of
enzyme added and incubated for a further 4 h. Sequential digests for
recovery of disaccharides for SAX-HPLC analysis were performed in the
presence of 100 mg of nonlabeled HS at 37 °C as follows: heparinase for
2 h, heparitinase for 1 h, heparitinase II for 18 h, and finally an aliquot
of each lyase and heparitinase IV for 6 h. Sample volumes were de-
creased to less than 100 ml by desiccation and run on a Bio-Gel P-2
column to isolate disaccharides.
Gel Chromatography—Gel chromatography of intact chains or scis-
sion products was performed on Sepharose CL-6B (1 3 120 cm) or
Bio-Gel P-2 (1 3 120 cm) or Bio-Gel P-10 (1 3 200 cm) columns. The
running buffer for the CL-6B and Bio-Gel P-10 columns was 0.5 M
NH4HCO3 and for the Bio-Gel P-2 column was 0.25 M NH4HCO3.
Samples were routinely eluted at 4 ml/h with 1-ml fractions collected.
For preparative runs, the radioactivity of a small aliquot of each frac-
tion (1–10 ml) was monitored by liquid scintillation counting to ensure
good separation and accurate isolation of fragments for further analy-
sis. Estimates of the size of fragments resolved on Sepharose CL-6B
were based on published calibrations (30).
SAX-HPLC Analysis of Disaccharides and Tetrasaccharides—Disac-
charide composition of the HS was analyzed on SAX-HPLC after either
complete depolymerization with a mixture of lyases as described above
or HNO2 treatment. Disaccharides and/or tetrasaccharides were recov-
ered by Bio-Gel P-2 chromatography and fractions corresponding to
disaccharides or tetrasaccharides were pooled, freeze dried, and stored
at 220 °C. The lyase-derived disaccharides were subjected to SAX-
HPLC on a ProPac PA1 analytical column (4 3 250-mm Dionex Ltd.) as
follows. After equilibration in the mobile phase (double-distilled water
adjusted to pH 3.5 with HCl) at 1 ml/min, samples were injected and
disaccharides eluted with a linear gradient of NaCl from 0 to 1 M over
45 min in the same mobile phase. The eluant was collected in 0.5-ml
fractions and monitored for tritium-labeled disaccharide content for
comparison with lyase-derived disaccharides standards. Nitrous acid-
derived tetrasaccharides were subjected to the same conditions (with
0.25- or 0.5-ml fractions collected) and compared with double labeled
standard results which were supplied by Dr. Gordon Jayson (Christie
Hospital, Manchester, UK). Alternatively, HNO2-derived disaccharides
were separated using two ProPac PA1 columns in series in the same
mobile phase. A shallow, non-continuous gradient was used over the
course of 97 min. After a 1-min injection phase, a 50-min gradient from
0 to 150 mM NaCl was employed, followed by a 70-min gradient of
150–500 mM NaCl. The eluant was collected as described above and
compared with standards. Major peaks are labeled in Fig. 3A and three
minor disaccharide peaks eluted as follows: GlcA(2S)-AManR between
43.75 and 44 min, GlcA-AManR(3S) between 45.75 and 46.5 min, and
GlcA-AManR(3,6S) between 104 and 106 min.
Nitrocellulose Filter Binding Assays—Nitrocellulose filter binding
assays were performed as described previously (34) with modifications.
Briefly, 3H-labeled HS samples were incubated with 5 mg of the appro-
priate FGF for 10 min at 37 °C in 0.5 ml of 10 mM Tris-HCl buffer, pH
7.0, and the complex immobilized by vacuum filtration onto a 25-mm
diameter nitrocellulose filter. The HS was then step eluted by consec-
utively vacuum filtering a series of 10 mM Tris-HCl, pH 7.0, solutions (5
ml each) containing increasing concentrations of NaCl (250, 500, 750,
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1000, 1250, 1500, and 2000 mM) through the nitrocellulose membrane.
Radioactivity in the filtrate at each NaCl concentration was measured
by scintillation counting.
RESULTS
The structural features of the HS chains were investigated
using established protocols (12, 35–37). HS chains (derived by
Pronase and mild alkali treatment) were chromatographed on
Sepharose CL-6B columns either intact, or after heparinase
treatment (Fig. 1 and Table I). Both pools of HSPGs showed a
partial resistance to proteolysis by Pronase, characteristic of
proteoglycans, which are densely substituted with polysaccha-
ride chains. This data indicates that there are at least two HS
chains per core protein in each preparation, and that their
attachment sites are located close together. HS2 and HS1
eluted at Kav of 0.46 and 0.36, respectively, which corresponds
to average molecular masses of 25 and 40 kDa when compared
with published calibrations (30). Assuming an average molec-
ular mass of 400 Da per disaccharide, HS2 and HS1 are 60 and
100 disaccharides in length, respectively. The HS expressed
early in development is thus smaller than the more mature
chains, indicating significant structural changes underlying
the functional differences exhibited in previous studies.
Low pH HNO2 Treatment—To determine the number and
general organization of N-sulfated disaccharides the HS sam-
ples were subjected to low pH HNO2 treatment. Low pH scis-
sion releases the N-sulfate groups from heparan sulfate with
subsequent cleavage of the adjacent hexosaminidic bond. This
gave elution profiles (Fig. 2A) with a typical distribution of
N-sulfated disaccharides characteristic of HS (38). From these
profiles it is possible to calculate the percentage of linkages
susceptible to this treatment and thus the percentage of N-
sulfated glucosamine residues in the HS chains. HS2 was sig-
nificantly more susceptible to nitrous acid cleavage than HS1
(Table II). As the similarities between the profiles confirm, the
results also show the strong tendency of the N-sulfated disac-
charides to occur in contiguous or mixed sequences. There is a
small decrease in the proportion of repeating N-acetylated di-
saccharide sequences in HS1 that might be due to a reduction
in the spacing between the sulfated domains.
Chromatography of Lyase-treated HS—Heparinase-treated
oligosaccharides were separated on a Bio-Gel P-10 column (Fig.
2B). The molecular mass of the heparinase-resistant domains
in HS corresponds to the average distance between the centers
of highly sulfated regions which contain heparinase-suscepti-
ble linkages. Analysis of the percentage of small oligosaccha-
rides (degree of polymerization 2–6) (inset Fig. 2B) released by
this treatment revealed that HS2 released approximately 50%
fewer small oligosaccharides then HS1. Estimation of the mo-
lecular size of the material excluded from the P-10 column by
CL-6B chromatography (Fig. 1B) showed that the major peaks
correspond to molecular weights of 7,000 and 5,000 (Table I),
respectively, for HS2 and HS1, although there is considerable
overlap of the two peaks, indicating a broad similarity in size
distribution. The results do suggest a tendency for closer aver-
age positioning of the sulfated domains in the more mature E12
chains, although more work will have to be done to confirm this
point. Heparinase therefore cuts the HS2 chains into 3–4 seg-
ments but in contrast cuts the HS1 chains into 7–8 segments.
HS2 is therefore less complex in domain structure than HS1.
Heparitinase treatment of the samples yielded elution profiles
(Fig. 2C) which were also characteristic of HS (12). The hep-
aritinase cleavage also tends to confirm that the sulfated do-
mains are broadly similar in size from E10 to E12, the only
significant difference being a decrease in the tetrasaccharide
peak in HS1. Quantitative analysis of the profiles demon-
strated that 61 and 65% of the linkages in HS2 and HS1 were
susceptible to this treatment, respectively (i.e. GlcA-containing
disaccharides), a result which indicates that the sizes of the
(heparitinase-resistant) sulfated domains in both E10 and E12
material are broadly similar. The remaining disaccharides
must contain IdoA or IdoA(2S), indicating that there is a
slightly higher content of IdoA(62S) residues in HS2 chains.
Since HS2 is less susceptible to heparinase (Table II), which
cleaves at IdoA(2S) residues, and contains less 2-O-sulfated
disaccharides (see Tables III and IV) this indicates that it
contains a higher level of unsulfated iduronate than HS1.
SAX-HPLC of Nitrous Acid-generated Disaccharides—Oligo-
saccharides derived by HNO2 treatment of HS were reduced
with sodium borohydride, separated on a Bio-Gel P-2 column,
pooled, and freeze dried. SAX-HPLC separation of disacchar-
ides resulted in the elution profiles in Fig. 3. Nitrous acid
FIG. 1. Gel filtration on Sepharose CL-6B of HS chains and
fragments. Heparan sulfate from primary neuroepithelial cells (A and
B) was isolated and the size of the full-length chains (A) and hepari-
nase-resistant fragments (B) determined using a Sepharose CL-6B gel
filtration column (HS2, —; HS1, - - -). The results are summarized in
Table I.
TABLE I
A summary of the estimated Mr of extracellular-HS from the two
samples examined in this study
All HS samples were subjected to separation on a 1 3 120-cm Sepha-
rose CL-6B column after a variety of treatments. The size of purified
full-length HS was determined both before and after mild alkali treat-
ment to determine the presence of more than one chain per protein core.
In addition, the approximate distance between heparinase-sensitive
disaccharides was determined by isolating the non-resolved, large oli-
gosaccharides from a Bio-Gel P-10 column (Fig. 2B, Vo peak) and re-
running them on a Sepharose CL-6B column.
Condition HS2 HS1
Pronase (Da) 40,000 70,000
Mild alkaline (Da) 25,000 40,000
Heparinase (Da) 7,000 5,000
No. heparinase-resist domains 2 7–8
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cleaves hexosaminidic bonds in HS leading to the production of
saccharides with an authentic nonreducing end uronic acid, but
the loss of N2 from the reducing end glucosamine and its
conversion to a 2,5-anhydromannose residue. For SAX-HPLC,
this moiety was reduced to 2,5-anhydromannitol. Each disac-
charide peak was identified according to its elution time in
comparison with standard HNO2-derived disaccharides. These
results are summarized in Table III where the area under each
peak has been integrated and shown as a percentage of total
disaccharides released by HNO2 digestion. The major differ-
ences are a decrease in IdoA(2S)-AManR and increases in both
IdoA(2S)-AManR(6S) and GlcA(2S)-AManR accompanying the
transition from E10 to E12. Overall, there is a slight increase in
total sulfation in the contiguous N-sulfated domains of HS1
when compared with HS2. HS2 is therefore less sulfated than
its more mature counterpart HS1.
Analysis of the Total Disaccharide Composition of the HS
Pools—To fully characterize the composition of the samples of
HS, the chains were subjected to complete lyase depolymeriza-
tion using heparitinases I, II, III, and IV. The products of this
digestion were separated on a Bio-Gel P-2 column with over
95% of the radioactivity accounted for in the disaccharide peaks
(data not shown), indicating sufficiently complete digestion to
provide a representative compositional analysis. For analysis
on SAX-HPLC, the disaccharides were pooled and freeze dried.
The peaks in Fig. 4 were identified by reference to authentic
standards (38, 39). Overall, the disaccharide compositions of
the HS samples were broadly similar (Table IV). However,
there were significant increases in the trisulfated disaccharide
DHexUA(2S)-GlcNSO3(6S) and in the disaccharide DHexUA-
(2S)-GlcNAc in the E12-derived HS1. Based on this data, com-
parisons of the sulfation characteristics can be made (Table V).
N-Sulfation was identical, whereas O-sulfation was slightly
higher in HS1 relative to HS2, due mainly to a higher level of
2-O-sulfation, with only a small increase in 6-O-sulfation
apparent.
SAX-HPLC of Nitrous Acid-generated Tetrasaccharides—
The tetrasaccharide products isolated after an HNO2 depoly-
merization were separated by SAX-HPLC (Fig. 5). The general
structure of tetrasaccharides is HexA-GlcNac-Glc-AHM, and
O-sulfation can occur at C-6 of the amino sugars, C-2 of the
nonreducing terminal uronic acid, and at C-3 of GlcNSO3.
Current knowledge of HS biosynthesis and structure indicates
that HNO2-resistant tetrasaccharides are likely to flank the
contiguous N-sulfated domains (12, 20). The positions of non-,
mono-, and disulfated peaks were established by comparison
with dual 35S/3H-labeled samples run under identical condi-
tions. The percentage of each of the designated peaks as com-
pared with the total population is summarized in Table VI. The
level of the nonsulfated peak (UAa1–4GlcNAcb1–4GlcAa1–
4AManR tetrasaccharides) was similar in the HS from E10 and
E12. However, the proportions of nearly all of the monosulfated
FIG. 2. Gel filtration on Bio-Gel P-10 of oligosaccharides pro-
duced by various depolymerizing agents. HS from primary neuro-
epithelial cells (A-C) was isolated as described in the text and was
fractionated on a Bio-Gel P-10 column (1 3 200 cm) after the following
treatments. A, low pH HNO2 depolymerization. A small aliquot was
fractionated on a Bio-Gel P-10 column and the rest of this digested
sample was run on a Bio-Gel P-2 column (1 3 120 cm) to isolate the
tetrasaccharides and disaccharides for SAX-HPLC analysis. This pro-
file was used to calculate the percentage of HNO2 susceptible linkages
(Table II). A large fraction of this digest sample was run on a Bio-Gel
P-2 column (1 3 120 cm) to isolate the tetrasaccharides and disaccha-
rides for SAX-HPLC analysis. C, depolymerization by heparitinase: the
susceptibility of each species to heparitinase was calculated from this
profile and tabulated in Table II. The degree of polymerization of each
peak is represented by the number above that peak and was subse-
quently used in the calculations. B, depolymerization by heparinase:
inset, fractions 64–115 of the heparinase scission profile with an ex-
panded scale to reveal the proportions of low Mr products. The nonre-
solved Vo peak was pooled, freeze dried, and resolved on a Sepharose
CL-6B (Fig. 1).
TABLE II
Proportion of the linkages susceptible to low pH HNO2, heparitinase
and heparinase in HS2 and HS1
Radiolabeled heparan sulfate from the two different sources was
treated with low pH HNO2, heparinase, or heparitinase and fractioned
on a Bio-Gel P-10 column as described in the text. The percentage of the
total treatment-sensitive linkages was determined in two separate ex-
periments by SAn/n, where An is the percentage of total radioactivity in
that peak, and n is the number of disaccharide repeat units in the
oligosaccharides as determined by the elution position.
Treatment HS2 HS1
%
Heparitinase 61.5 65
Heparinase 15.3 16.7
HNO2 49.0 53.0
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peaks changed significantly, especially peaks 1 and 7, which
decreased by 60 and 29%, respectively, and peak 5 which in-
creased by 125%. The disulfated and trisulfated peaks also
show small but significant changes in levels, and overall there
is a slight trend toward increased sulfation at E12 in these
tetrasaccharides. Thus, the tetrasaccharide analysis approach
revealed considerable structural differences between the two
HS pools, confirming the increased complexity in sulfation
patterns during development.
Binding Assays—To confirm that the isolated heparan sul-
fate chains retain their binding specificities for particular
FGFs, filter binding assays were performed. FGF-2 or FGF-1
were pre-mixed with either HS2 or HS1, and the complexes
formed captured on a nitrocellulose filter and step eluted with
FIG. 3. Strong anion exchange-high pressure liquid chromatography of HNO2-generated disaccharides. Disaccharides produced by
low pH HNO2 were isolated by Bio-Gel P-2 low pressure chromatography, freeze dried, and separated by SAX-HPLC. Disaccharides were eluted
as described under “Experimental Procedures.” The elution times of the peaks were compared with those of authentic standards and labeled
accordingly. A representative elution profile from HS2 disaccharides is shown in A and HS1 disaccharides in B. The relative amounts of each of
the peaks has been calculated and summarized for both HS pools in Table III.
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increasing concentrations of NaCl (Fig. 6). The results showed
that the E10-derived HS pool, HS2, binds FGF-2 strongly and
with a markedly greater affinity than for FGF-1. The E12-
derived HS pool, HS1, also binds FGF-2, albeit a little more
weakly than HS2 and would also appear to have, relative to
HS2, an enhanced affinity for FGF-1.
DISCUSSION
A mixture of structurally complex chain sequences are gen-
erated during the biosynthesis of HS and the data generated
here represent the average for each pool of HS isolated. The
analysis reported here makes clear that chain organization and
fine structure differs systematically between key developmen-
tal stages, although the core protein carrying these different
chains remains constant (6). By integrating all the structural
data we have produced a simplified model to summarize the
most significant changes in structure of the neuroepithelial
HSs (Fig. 7). Previous studies characterizing skin fibroblast HS
led to a model which posited the now widely accepted domain
structure model of HS (11, 12). It was concluded that hepari-
nase-sensitive disaccharides are located in short domains con-
sisting of GlcNSO3(66S)-IdoA(62S) repeats. These are sepa-
rated by regions of polysaccharide that are heparinase
resistant, enriched with N-acetylated disaccharides, and low in
FIG. 4. Strong anion exchange-high
pressure liquid chromatography of
HS disaccharides. Disaccharides pro-
duced by lyase depolymerization were
separated by SAX-HPLC. The elution
times of the peaks were compared with
whose of authentic standards and numer-
ically labeled accordingly. The numbers
correspond with numbers in Table IV
which summarizes the relative abun-
dance of each of the disaccharides. Repre-
sentative elution profiles from HS2 disac-
charides (A) and HS1 disaccharides (B).
TABLE III
Nitrous acid-derived disaccharide composition of heparan sulfate from
HS preparations from two developmental stages of neuroepithelia
Radiolabeled HS was depolymerized by deaminative cleavage with
low pH HNO2. Disaccharides were isolated on a 1 3 120-cm Bio-Gel P-2
column. The resulting disaccharides were fractionated by SAX-HPLC
as described in the text. The area under each peak in Fig. 3 was integrated
to give the percentage composition in each sample. The numbers in the
table are the average of three experiments which did not vary .5%.
Disaccharide HS2 HS1
IdoA/GlcA-AManR 12.9 13.9
IdoA(2S)-AManR 53.4 44.8
GlcA-AManR(6S) 10.2 11.4
IdoA-AManR(6S) 3.4 2.7
IdoA(2S)-AManR(6S) 18.7 24.8
GlcA(2S)-AManR 1.0 1.8
GlcA-AManR(3S) 0.30 0.4
GlcA-AManR(3,6S) 0.15 0.2
Unknown 0.0 0.0
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both iduronic acid and sulfate moieties. Following this discov-
ery, many other HS pools have been characterized which are
similar in their overall organization (36, 37, 39, 40); this study
demonstrates that HS derived from primary neuroepithelial
cells conform to this structural theme, and to our knowledge
represents the most detailed characterization to date of HS
derived from primary cells. Apart from the increase in chain
size and number of sulfated domains per chain in HS1, the data
indicate basic similarities in domain structure, but with dis-
tinct O-sulfation patterns imposed on these domains. These
alterations must be the basis for the changes in binding and
activation of FGF2 and FGF1 previously reported (6). The main
difference in fine structure between the two HSs is an obvious
increase in sulfation at E12, which indicates that 2-O- and
6-O-sulfotransferases are significantly more active at the E12
as opposed to the E10 stage of development. However, it is
when the disaccharides released by HNO2 are studied that the
distinctions become most clear, with HS1 showing a reproduc-
ibly higher amount of 6-O-S specifically in the disulfated spe-
cies IdoA(2S)-AManR(6S); this shows that a highly regulated
sulfotransferase activity is targeted to specific GlcNSO3 resi-
dues within contiguous sequences of N-sulfated disaccharides.
Data on the tetrasaccharides released by HNO2 also support
the view that regulation of O-sulfotransferases creates subtle
differences in patterns of O-sulfation in the HS at different
developmental stages.
Analysis of the disaccharides from HNO2-degraded HS from
the neuroepithelium corresponds with the relative amounts of
HS-derived disaccharides found in the conditioned medium of a
hepatocyte cell line, in that there is a high proportion of
IdoA(2S)-AManR, followed by IdoA(2S)-AManR(6S) and IdoA/
GlcA-AManR (26). There is a significant decrease in IdoA(2S)-
AManR and an increase in GlcA-AManR(6S) in the transition
from E10, the proliferative influence, to E12, the differentiative
influence. In addition, HS1 is significantly different from HS2
in that it contains approximately 50% more of the trisulfated
disaccharide HexA(2S)-GlcNSO3(6S). Both of these results may
reflect the crucial role suggested for 6-O-sulfates in binding
FGF-1 and potentiating its activity in vivo (41, 42). Similar to
hepatocytes, there is an increase in total sulfation in the E12
cells over less differentiated, E10 cells (26). Fedarko and Con-
rad (26) hypothesized that this reflects HS chains with longer
sulfated domains and shorter non-sulfated domains in the con-
fluent as opposed to dividing cells. In contrast, our data indi-
cate that the two neuroepithelial HS species are very similar in
domain sizes, with the main overall structural change in the
E12-derived HS being the extra chain length, presence of a
smaller proportion of N-acetylated sequences (which may con-
tribute to the closer spacing of the heparinase cleavage sites)
and a larger number of sulfated domains. Differences in the
fine structure of HS recovered from syndecan-1 proteoglycan
have been observed in terms of disaccharide composition, the
arrangement of lyase cleavage sites, and in the length and
number of highly sulfated domains. These changes appeared to
underlie differences in the ability of HS to bind collagen but not
FGF-2 (27, 40). This supports the idea proposed here that cells
preferentially modify HS chains attached to a specific core
protein to enable the HSPG to perform specific functions (43).
The filter binding assays suggest that HS2 has an enhanced
affinity for FGF2 relative to HS1 and that this situation is
reversed with respect to their binding of FGF1. While the
differences may appear slight, HS1 and HS2 are, in fact pools
of HS made in the developing tissue at the different ages.
Consequently the subtle differences found here must reflect
significant structural changes taking place in these pools dur-
ing development which are necessary to appropriate function in
an increasingly complex environment. These changes comple-
ment the expression of these two growth factors in the devel-
oping neuroepithelium (6, 7). It is also important to remember
that this binding assay can assess one event only, the HS-FGF
interaction, of the ternary interaction (HS-FGF-FGFR) thought
to be required to initiate specific cell signaling. Thus, it is likely
that distinct sequences required for biological activation of
specific FGFs could be masked in simple binding assays by the
presence of other inactive sequences which are nevertheless
capable of binding FGFs. It is interesting to note that the intact
HSPG binds growth factors with higher affinities than the
heparan sulfate chains alone (6).2
One of the most interesting observations in this study is that
the HS from undifferentiated, dividing cells is both smaller and
simpler in structure than the HS from more differentiated,
contact-inhibited cells. We have also undertaken studies on HS
in an in vitro model with the 2.3D neuroepithelial cell line
derived from E10 cells, in which the transition from growth to
post-confluence parallels the E10 to E12 transition (6); overall,
the differences between the samples of HS from less differen-
tiated, growing cells and the HS from more mature, confluent
cells follow similar trends to those observed in the primary cells
(47). In view of the fact that the HS from the two less differ-
entiated sources (E10 primary cells and growing 2.3D cells)
2 V. Nurcombe, S. J. Joseph, and Y. Brickman, unpublished data.
TABLE IV
Lyase-derived disaccharide composition of heparan sulfate from the
two sources of HS
Heparan sulfate was isolated and completely depolymerized with a
mixture of heparan lyases. The resulting unsaturated disaccharides
were isolated on a P-2 column and fractionated by strong anion ex-
change-HPLC. The area under each peak in Fig. 4 was integrated to
calculate the percentage of each disaccharide in each sample. The
numbers represent the average of three experiments which did not vary
.5%. Over 97% disaccharides were recovered from each sample.
Peak Disaccharide HS2 HS1
%
1 DHexUA-GlcNAc 44.8 44.8
3 DHexUA-GlcNSO3 21.5 20.0
2 DHexUA-GlcNAc(6S) 8.0 6.7
7 DHexUA(2S)-GlcNAc 2.4 4.3
4 DHexUA-GlcNSO3(6S) 4.0 4.3
5 DHexUA(2S)-GlcNSO3 12.4 11.3
8 DHexUA(2S)-GlcNAc(6S) 0.2 0.3
6 DHexUA(2S)-GlcNSO3(6S) 4.1 6.4
9 Unknown 2.4 1.8
TABLE V
Sulfation characteristics of disaccharides from both HS pools
The calculations on sulfation characteristics shown are based on the
overall disaccharide composition data (Table IV). The data indicate
different levels of O-sulfation and sulfation ratios in these two HS
samples.
Sulfation HS2 HS1
%
Total sulfation/100
disaccharides
77.4 81
6-O-Sulfate 16.3 16.7
2-O-Sulfate 19.1 22.3
N-Sulfate 42.0 42.0
O-Sulfate 35.4 39
Ratios of sulfations
2-O-Sulfate/6-O-sulfate 1.17 1.33
N-Sulfate/O-sulfate 1.19 1.08
N-Sulfate/2-O-sulfate 2.2 1.88
N-Sulfate/6-sulfate 2.58 2.51
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bear the same FGF-2 potentiating activity (6), it follows that a
particular HS sequence motif embedded within the sulfated
domains may be common to both, and thus responsible for the
formation of an FGF-2zFGFR ternary complex. A similar argu-
ment would hold for an FGF-1 activating subdomain within HS
from E12 and confluent 2.3D cells. We know that HS from the
growing 2.3D cell line contains a subdomain which promotes
the interaction of FGF-2 with an FGFR (4). The exact compo-
sition of the sulfated domain which interacts with any specific
FGF and its cognate FGF receptor remains to be determined;
almost certainly the differences between chains that generate
such significant differential specificity between ligands are
quite subtle (18, 42, 43). However, the data presented here
strongly suggest that regulation of patterns of 6-O-sulfation
are a critical element. In addition, the spacing between the
growth factor-binding and any receptor-binding regions of an
HS molecule is likely to be significant to its recruitment into a
ternary complex and thus its bioactivity (4, 44–46). Our results
also carry the important implication that the use of heparin or
heparin fragments in tissue culture experiments as analogues
of HS to augment the activity of such agents as FGFs and other
HS-binding proteins is likely to mask crucial and complex in
vivo control mechanisms. Unlike HS, heparin does not consist
of discrete sulfated domains; heparin is a more extensively
epimerized and sulfated form of HS, with much larger propor-
tions of disaccharides that are trisulfated.
FIG. 5. SAX-HPLC of the tetrasac-
charides produced by HNO2. Tritiated
tetrasaccharides produced by low pH
HNO2 were isolated from Bio-Gel P-2 low
pressure chromatography, freeze dried,
and separated by high pressure liquid
chromatography and compared with dual
35S/3H-labeled standard results. The
numbers correspond to the order of the
left column of Table IV. HS2 and HS1
profiles are presented in A with a com-
plete profile, and B, an expanded axis
highlighting the fractions which are low
in abundance (HS2, —; HS1, zzz).
TABLE VI
SAX-HPLC separation of the HS-derived
tetrasaccharides produced by HNO2
Tritiated tetrasaccharides derived by low pH HNO2-treated heparan
sulfates were originally separated by low pressure chromatography on
a Bio-Gel P-2 column and were then further resolved by high pressure
liquid chromatography. The percentage of each tetrasaccharide was
determined by calculating the radioactivity in each peak and comparing
it to the total radioactivity in all peaks combined. Tetrasaccharide peak
numbers in the left column correspond to the peaks in Fig. 5. Minor
peaks comprise less than 12% of total tetrasaccharides. The degree of
sulfation was determined by comparison of these tritiated samples with
peaks generated by dual 35S/3H-radiolabeled samples (from Dr. Gordon
Jayson, University of Manchester) run on the same column under
identical conditions. The numbers represent the average of three sep-
arate experiments.
Sulfation number:peak HS2 HS1
%
Non-sulfated 37.2 34.7
Monosulfated:1 1.5 0.6
Monosulfated:2 1.0 0.7
Monosulfated:3 0.3 0.2
Monosulfated:4 0.3 0.4
Monosulfated:5 7.7 17.3
Monosulfated:6 23.9 21.6
Monosulfated:7 18.4 13.1
Minor di- and trisulfated 9.7 11.4
Total 100 100
HS Structure Differs in Dividing and Differentiating Cells 4357
 at UQ Library on October 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
As HS must serve a variety of different functions in vivo, the
structural differences between HS chains must be designed to
selectively produce specific functional properties. It is highly
likely that these differences are the key to the individual and
specific functions of HS in the extracellular environment, al-
though methods for direct sequencing of HS saccharides will be
required to substantiate this view. The fundamental hypothe-
sis underlying the present study was that the functional
changes in the FGF activating activities of secreted HS from
either dividing or differentiating cells were due to systematic
changes in the saccharide sequences of the HS chains. The
differences in the structure of the two kinds of HS species found
in this study are compatible with the idea that distinct HS
sequences are expressed to selectively activate different FGFs,
and that during embryonic development a non-committed cell
type has the potential to vary the HS structure in response to
epigenetic or environmental cues. Taken together with similar
results from the structural analyses of other HS-binding mol-
ecules such as antithrombin III, hepatocyte growth factor, and
interferon-g, we predict that every molecule that requires HS
for activation will have a distinct and specific disaccharide
sequence motif dedicated to regulation of its biological activity.
Thus, HS chains with different repertoires of distinct se-
quences will be generated by cells dependent on their need to
orchestrate the activity of specific HS-binding proteins. Cur-
rently such molecules encompass members of the transforming
growth factor-b family, the platelet-derived growth factor fam-
ily, all of the FGFs, the pleiotropin-like family, and structural
molecules such as the laminins, the fibronectins, the amyloid
precursor protein family and the collagens, among many oth-
ers. We further suggest that such HS-binding molecules will
have configurations of basic amino acids which are spatially
distinctive for the binding of such HS sequences.
Another important question raised by our data is how a
single cell type regulates the switching of the production of one
class of HS chain for another, closely related chain. We have as
yet no data which informs us whether the sudden production of
FGF-1 in E12 cells induces a change in HS synthesis, or
whether the new HS is made in readiness for the growth factor
switch. In vivo, this is an interesting question, as differentia-
tion of hundreds of different subclasses of neurons and glia
commences at these stages of mouse brain development. Recent
evidence from our laboratory has tended to confirm our original
hypothesis that the sudden synthesis of FGF-1 is a key event in
the subsequent emergence of the neuronal lineage; if this is
true, the change in HS specificity toward promotion of FGF-1
bioactivity becomes a seminal event in the appearance of neu-
rons. This hypothesis can now be tested by specifically inter-
fering with the enzymatic processes of those 6-O-sulfotrans-
ferases which construct the subtle differences in HS structure
at each developmental stage, and monitoring for changes in
subsequent rates of neuronal differentiation.
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